The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH AL 2020 | Intensive therapy of older AML
Thorsten Braun, MD, PhD, Hôpitaux de Paris, Université Paris 13, Bobigny, France, discusses current intensive therapy of older acute myeloid leukemia (AML) patients. Analysis of AML gene mutations can improve treatment stratification of patients who may benefit from intensive therapy and allogeneic transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
